Literature DB >> 20398036

Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer.

Mahdi Aghili1, Shahrzad Izadi, Hossein Madani, Hossein Mortazavi.   

Abstract

AIM: To compare the characteristics of primary cancer between patients with early recurrence and those with late recurrence of colorectal cancer.
METHODS: Overall 535 patients with primary colorectal cancer were reviewed and of these 130 patients with demonstrated recurrence were evaluated. Of the 130 patients, 91 had early recurrence (less than 2 years after surgery) and 39 had late recurrence (2 years or more after surgery). The clinical and pathological characteristics of primary cancer in these two groups were compared.
RESULTS: The rate of late recurrence was 30% of total recurrences (39/130). On average, patients with early recurrence were younger than patients with late recurrence (mean age 48 vs 54 years, p = 0.027). Adjacent organ involvement and Dukes stage C was more prevalent in the early recurrence group than in the late group. The liver was the main site of distant recurrence in the early recurrence group (64% of distant recurrences), whereas bone and peritoneum were the most frequent sites of metastases in the late recurrence group (58%). In Dukes C colon cancer patients the disease-free interval was significantly longer in those who received both adjuvant therapies than in those who received either radiotherapy or chemotherapy or neither of them.
CONCLUSION: This study showed that factors such as primary clinical signs, stage of primary tumor, and adjacent organ involvement are significant with respect to the time for recurrence of colorectal cancer. It is important to take these characteristics into account in patient care management after curative resection for colorectal cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20398036     DOI: 10.1111/j.1743-7563.2010.01275.x

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  25 in total

Review 1.  Molecular mechanism of adenomatous polyposis coli-induced blockade of base excision repair pathway in colorectal carcinogenesis.

Authors:  Satya Narayan; Ritika Sharma
Journal:  Life Sci       Date:  2015-09-01       Impact factor: 5.037

2.  Response to the letter to the editor regarding the manuscript entitled "positron emission tomography with [(18)F]-3'-deoxy-3'fluorothymidine (FLT) as a predictor of outcome in patients with locally advanced resectable rectal cancer: a pilot study".

Authors:  Farrokh Dehdashti; Perry W Grigsby; Barry A Siegel
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

3.  Regulation of colon cancer recurrence and development of therapeutic strategies.

Authors:  Shailender Singh Kanwar; Anuradha Poolla; Adhip Pn Majumdar
Journal:  World J Gastrointest Pathophysiol       Date:  2012-02-15

4.  Loss of APAF-1 expression is associated with early recurrence in stage I, II, and III colorectal cancer.

Authors:  Byung Kyu Ahn; Sung Hoo Kim; Seung Sam Paik; Kang Hong Lee
Journal:  Langenbecks Arch Surg       Date:  2016-08-02       Impact factor: 3.445

5.  Clinicopathologic factors affecting recurrence after curative surgery for stage I colorectal cancer.

Authors:  Min Ae Keum; Seok-Byung Lim; Sun A Kim; Yong Sik Yoon; Chan Wook Kim; Chang Sik Yu; Jin Cheon Kim
Journal:  J Korean Soc Coloproctol       Date:  2012-02-29

6.  Do clinicopathologic features of rectal and colon cancer guide us towards distinct malignancies?

Authors:  Abbas Rezaianzadeh; Salar Rahimikazerooni; Hajar Khazraei; Seyed Mohammad Kazem Tadayon; Mohammad Abdzaid Akool; Masomeh Rahimi; Seyed Vahid Hosseini
Journal:  J Gastrointest Oncol       Date:  2019-04

7.  Defining early recurrence in patients with resected primary colorectal carcinoma and its respective risk factors.

Authors:  Felix Wiesmueller; Rolf Schuetz; Melanie Langheinrich; Maximilian Brunner; Georg F Weber; Robert Grützmann; Susanne Merkel; Christian Krautz
Journal:  Int J Colorectal Dis       Date:  2021-01-15       Impact factor: 2.571

8.  Bisphosphonate and risk of cancer recurrence: protocol for a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials.

Authors:  Yupeng Liu; Chen Du; Yuxue Zhang; Shu Zhao; Lina Zhao; Pengfei Li; Fulan Hu; Lin Zhu; Yanlong Liu; Da Pang; Yashuang Zhao
Journal:  BMJ Open       Date:  2015-04-21       Impact factor: 2.692

9.  Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.

Authors:  Klaas Ehrig; Mehmet O Kilinc; Nanhai G Chen; Jochen Stritzker; Lisa Buckel; Qian Zhang; Aladar A Szalay
Journal:  J Transl Med       Date:  2013-03-26       Impact factor: 5.531

10.  Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expression.

Authors:  Bojian Fei; Alfred L Chi; Yuan Weng
Journal:  World J Surg Oncol       Date:  2013-05-30       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.